Severe acute interstitial lung disease induced by crizotinib therapy in a patient with c-Met amplification non-small cell lung cancer.

Author: Youxin JI ¹ ; Zhongfa ZHANG ² ; Keke NIE ² ; Ketao LAN ² ; Chuanxin GENG ² ; Shichao LIU ² ; Ling ZHANG ² ; Zongchun ZHANG ² ; Lei SUN ² ; Xiao ZOU ²
Author Information

1. Department of Oncology, Qingdao Central Hospital, Second Affiliated Hospital of Qingdao University, Qingdao, Shandong 266042, China. Email: mdji001@gmail.com.
2. Department of Oncology, Qingdao Central Hospital, Second Affiliated Hospital of Qingdao University, Qingdao, Shandong 266042, China.
Publication Type:Case Reports
MeSH: Carcinoma, Non-Small-Cell Lung; drug therapy; Humans; Lung Diseases, Interstitial; chemically induced; diagnosis; Male; Middle Aged; Protein Kinase Inhibitors; adverse effects; therapeutic use; Pyrazoles; adverse effects; therapeutic use; Pyridines; adverse effects; therapeutic use
From: Chinese Medical Journal 2014;127(8):1600-1600
CountryChina
Language:English